Hedox

Hedox is an oral, prescription medication that contains the active ingredient finasteride. It is marketed in the European Union as a 5‑alpha‑reductase inhibitor, typically supplied in tablet form. Finasteride works by reducing the conversion of testosterone to dihydrotestosterone (DHT). Hedox is used under medical supervision for specific androgen‑related conditions in men. The product is intended for adult male patients and requires a prescription from a qualified healthcare professional.

Hedox is prescribed for conditions that involve excess dihydrotestosterone (DHT) in men. The medication is indicated for two primary therapeutic areas, each supported by clinical evidence.

- Male pattern hair loss (androgenetic alopecia) in men - Benign prostatic hyperplasia (BPH) associated with urinary symptoms - Prevention of prostate enlargement progression - Management of DHT‑related scalp thinning - Adjunct therapy when other treatments are insufficient

Finasteride may cause a range of side effects, most of which are mild and reversible after discontinuation. Side effects are grouped by frequency and severity.

Common: - Decreased libido - Erectile dysfunction - Ejaculation disorders - Reduced semen volume - Breast tenderness or enlargement

Serious: - Allergic reactions such as rash, itching, swelling - Testicular pain - Persistent depression or mood changes - Male breast cancer (rare)

Before starting Hedox, patients should discuss their medical history and current medications with a healthcare provider to assess suitability and minimize risks.

- Not for use in women or children; pregnancy category X - Contraindicated in men with known hypersensitivity to finasteride - Caution in patients with liver impairment - Regular monitoring of prostate-specific antigen (PSA) levels is recommended - Inform doctor of any history of depression or mood disorders - Discuss potential effects on sexual function before initiating therapy

Finasteride can interact with other medicines, affecting its efficacy or increasing the risk of adverse events. Interactions are categorized by the level of clinical concern.

Avoid: - Co‑administration with strong CYP3A4 inhibitors (e.g., ketoconazole) that may increase finasteride levels - Use with other 5‑alpha‑reductase inhibitors (e.g., dutasteride) due to overlapping mechanisms

Use with caution: - Anticoagulants or antiplatelet agents, monitoring for bleeding - Hormonal therapies that alter androgen levels - Certain antidepressants, observing mood changes - Herbal supplements such as saw palmetto, which also affect DHT